In fact, GFAP is an indicator of neuroinflammation in the CNS25 and it is also involved in the progression of neurodegeneration in ischemia, AD, MS, Amyotrophic Lateral Sclerosis (ALS) and PD26–28. Here, GFAP is linked to amyotrophic lateral sclerosis.